Fol. Biol. 2016, 62, 258-262
https://doi.org/10.14712/fb2016062060258
Comparison of Plasma Osteopontin Levels between Patients with Borderline Ovarian Tumours and Serous Ovarian Carcinoma
Crossref Cited-by Linking
- Ögren Jim Åkerrén, Ekström Joakim, Rameika Natallia, Torell Emma, Larsson Chatarina, Stoimenov Ivaylo, Micke Patrick, Gyllensten Ulf, Hellström Mats, Glimelius Bengt, Stålberg Karin, Sjöblom Tobias: Composite proteomic and metabolomic plasma biomarkers for detection of colorectal, lung and ovarian cancers. Mol Cancer 2026, 25. <https://doi.org/10.1186/s12943-026-02654-1>
- Molina-Pineda Andrea, Jauregui-Salazar Francisco Osiel, Zamudio-Martínez Aleyda Guadalupe, Vizcarra-Ramos Sayma, García-Gómez Jesús, González-Amézquita Benjamín, Aguilar-Vazquez Lizeth Montserrat, Villegas-Pacheco Raquel, Hernandez-Gutierrez Rodolfo, Jave-Suárez Luis Felipe, Aguilar-Lemarroy Adriana: Utility of a Multimodal Biomarker Panel and Serum Proapoptotic Activity to Refine Diagnosis of Ovarian Adnexal Masses. Diseases 2025, 13, 342. <https://doi.org/10.3390/diseases13100342>
- Villanueva Francisco, Araya Hector, Briceño Pedro, Varela Nelson, Stevenson Andres, Jerez Sofia, Tempio Fabian, Chnaiderman Jonas, Perez Carola, Villarroel Milena, Concha Emma, Khani Farzaneh, Thaler Roman, Salazar\u2010Onfray Flavio, Stein Gary S, van Wijnen Andre J., Galindo Mario: The cancer\u2010related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis. Journal Cellular Physiology 2019, 234, 13659. <https://doi.org/10.1002/jcp.28046>
- Han Xingwen, Wang Wenji, He Jingjing, Jiang Lei, Li Xun: Osteopontin as a biomarker for osteosarcoma therapy and prognosis (Review). Oncol Lett 2019. <https://doi.org/10.3892/ol.2019.9905>
